CSF2 and neoplasm: Particularly, Wang et al. generated an engineered oncolytic virus that co-expressed PD-L1 inhibitor and granulocyte-macrophage colony-stimulating factor (GM-CSF) and found that it activated tumor neoantigen-specific T-cell responses [30].